Variant report
Variant | esv3384238 |
---|---|
Chromosome Location | chr4:28563604-28565602 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575587713 | chr4:28563634-28563635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544438273 | chr4:28563669-28563670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561099592 | chr4:28563712-28563713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139370682 | chr4:28563713-28563714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543059026 | chr4:28563739-28563740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559874049 | chr4:28563821-28563822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559591434 | chr4:28563829-28563830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528508883 | chr4:28563963-28563964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377251936 | chr4:28563971-28563972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571638698 | chr4:28563974-28563975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs193151410 | chr4:28564001-28564002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550909992 | chr4:28564038-28564039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567808020 | chr4:28564042-28564043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185657322 | chr4:28564146-28564147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368997521 | chr4:28564157-28564158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75838762 | chr4:28564166-28564167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187489987 | chr4:28564204-28564205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34502334 | chr4:28564282-28564283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538665677 | chr4:28564306-28564307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558559551 | chr4:28564311-28564312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575622640 | chr4:28564312-28564313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370664546 | chr4:28564354-28564355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375499209 | chr4:28564399-28564400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554469567 | chr4:28564408-28564409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574620371 | chr4:28564440-28564441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531759216 | chr4:28564443-28564444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377661335 | chr4:28564452-28564453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540046289 | chr4:28564471-28564472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559834155 | chr4:28564539-28564540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548976153 | chr4:28564569-28564570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528546469 | chr4:28564577-28564578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192006779 | chr4:28564578-28564579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377034748 | chr4:28564594-28564595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7690177 | chr4:28564598-28564599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs202227165 | chr4:28564603-28564604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs61269019 | chr4:28564610-28564611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373886176 | chr4:28564611-28564612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530842078 | chr4:28564635-28564636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564900961 | chr4:28564654-28564655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs112538320 | chr4:28564660-28564661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184241472 | chr4:28564737-28564738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567861502 | chr4:28564738-28564739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530351388 | chr4:28564748-28564749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546857174 | chr4:28564784-28564785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs2458615 | chr4:28564786-28564787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs538699972 | chr4:28564788-28564789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552209409 | chr4:28564905-28564906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143265636 | chr4:28564919-28564920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147512098 | chr4:28565001-28565002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554891651 | chr4:28565048-28565049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:28559600-28566600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:28561200-28564000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:28564000-28564200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:28564200-28564800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:28564800-28565400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr4:28565400-28568000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |